Artiva Biotherapeutics Income Statement (2023-2026) | ARTV

Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 0.81M18.90M11.26M24.34M24.38M24.48M24.44M24.68M
Revenue & cost
Revenue (Quarter) 3.50M26.66M2.35M0.25M
Operating items
Research & Development (Quarter) 11.26M13.06M11.15M11.16M12.33M13.52M13.32M17.05M17.86M17.63M16.99M19.31M
Selling, General & Administrative (Quarter) 4.06M2.78M3.17M3.59M3.86M4.81M4.95M5.12M4.95M5.26M4.94M5.12M
Operating Expenses (Quarter) 15.32M15.85M14.32M14.74M16.19M18.34M18.27M22.17M22.81M22.90M21.93M24.43M
Operating Income (Quarter) -11.82M10.81M-11.97M-14.49M-16.19M-18.34M-18.27M-22.17M-22.81M-22.90M-21.93M-24.43M
EBIT (Quarter) -11.82M10.81M-11.97M-14.49M-16.19M-18.34M-18.27M-22.17M-22.81M-22.90M-21.93M-24.43M
Non-operating items
Interest & Investment Income (Quarter) 0.51M0.42M0.58M0.65M0.68M1.85M2.18M1.86M1.56M1.37M1.16M0.91M
Other Non Operating Income (Quarter) 0.03M0.05M1.08M0.15M0.02M-0.98M-0.01M-0.00M-0.01M-0.00M-0.00M0.00M
Non Operating Income (Quarter) 0.54M0.47M0.04M0.53M-1.65M0.86M2.17M1.86M1.56M1.37M1.16M0.91M
Net income details
EBT (Quarter) -11.31M11.23M-11.60M-13.84M-28.05M-33.80M-23.21M-36.84M-36.75M-23.36M-21.18M-35.20M
Profit After Tax (Quarter) -11.28M11.42M-12.27M-13.96M-17.84M-17.47M-16.56M-20.31M-21.25M-21.53M-20.54M-23.64M
Income from Non-Controlling Interests (Quarter) -0.10M-0.09M0.22M-0.47M0.13M0.00M0.09M0.02M-0.12M
Income from Continuing Operations (Quarter) -11.31M11.23M-11.60M-13.84M-28.05M-33.80M-23.21M-36.84M-36.75M-23.36M-21.18M-35.20M
Consolidated Net Income (Quarter) -11.31M11.23M-11.60M-13.84M-28.05M-33.80M-23.21M-36.84M-36.75M-23.36M-21.18M-35.20M
Income towards Parent Company (Quarter) -11.31M11.23M-11.60M-13.84M-28.05M-33.80M-23.21M-36.84M-36.75M-23.36M-21.18M-35.20M
Net Income towards Common Stockholders (Quarter) -11.31M11.23M-11.60M-13.84M-28.05M-33.80M-23.21M-36.84M-36.75M-23.36M-21.18M-35.20M
Additional items
EPS (Basic) (Quarter) -14.1313.92-14.45-17.09-34.58-1.79-2.06-1.51-1.51-0.95-0.87-1.43
EPS (Diluted) (Quarter) -14.131.61-14.45-17.09-34.58-1.79-2.06-1.51-1.51-0.95-0.87-1.43
Shares Outstanding (Quarter) 0.80M0.81M0.80M0.81M0.81M18.90M11.26M24.34M24.38M24.48M24.44M24.68M
Shares Outstanding (Diluted) (Quarter) 0.80M6.97M0.80M0.81M0.81M18.90M11.26M24.34M24.38M24.48M24.44M24.68M
EBITDA (Quarter) -11.82M10.81M-11.97M-14.49M-16.19M-18.34M-18.27M-22.17M-22.81M-22.90M-21.93M-24.43M
Interest Expenses (Quarter) 0.21M12.54M17.31M7.12M16.53M15.50M1.84M0.41M11.68M